Latest Lucentis news
Repeated Ranibizumab Doesn’t Impair Macular Perfusion
by modernClinician Editorial Team
For patients with diabetic macular edema, repeated ranibizumab treatment does not appear to be associated with impaired macular perfusion, according to a study published online March 1 in JAMA Ophthalmology.
Aflibercept, Ranibizumab Not Cost-Effective Vs. Bevacizumab
by modernClinician Editorial Team
Compared with bevacizumab, aflibercept and ranibizumab are not cost-effective for diabetic macular edema, according to research published online June 9 in JAMA Ophthalmology.
AAO: Ranibizmab Noninferior to Panretinal Photocoagulation
by modernClinician Editorial Team
Treatment with ranibizumab is noninferior to panretinal photocoagulation for eyes with proliferative diabetic retinopathy, according to a study published online Nov. 13 in the Journal of the American Medical Association. The research was published to coincide with the annual meeting of the American Academy of Ophthalmology, held from Nov. 14 to 17 in Las Vegas.
Spinal Cord Stimulation Cuts Pain, Improves Sensation With Diabetic Nerve Damage
Very Low-Carb Diet Shows Greater Cardiometabolic Benefits Than Other Diets
Time-Restricted Eating May Help Patients With Type 1 Diabetes
Virtual Reality-Based Digital Defocus Vision Training May Aid Myopia in Children
Better Youth Fitness May Lower Risk for Depression in Adulthood
Autism Spectrum Disorder Diagnoses Increased for Females Since 2020
Highly Aspherical Lenslets Effective for Reducing Myopia Progression in Children
Internet-Based Cognitive-Behavioral Therapy Aids Children"s Anxiety Symptoms